vs

Side-by-side financial comparison of Sunrise New Energy Co., Ltd. (EPOW) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $22.3M, roughly 1.7× Sunrise New Energy Co., Ltd.). On growth, Sunrise New Energy Co., Ltd. posted the faster year-over-year revenue change (0.0% vs -57.1%).

Husky Energy Inc. was a Canadian petroleum company that existed from 1938 to 2021. It operated in Western and Atlantic Canada, the United States and the Asia Pacific region, with upstream and downstream business segments. In the 2020 Forbes Global 2000, Husky Energy was ranked as the 1443rd-largest public company in the world.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

EPOW vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.7× larger
ORGO
$37.2M
$22.3M
EPOW
Growing faster (revenue YoY)
EPOW
EPOW
+57.1% gap
EPOW
0.0%
-57.1%
ORGO

Income Statement — Q2 FY2025 vs Q1 FY2026

Metric
EPOW
EPOW
ORGO
ORGO
Revenue
$22.3M
$37.2M
Net Profit
$-6.0M
Gross Margin
0.1%
30.8%
Operating Margin
-24.3%
-185.1%
Net Margin
-27.1%
Revenue YoY
0.0%
-57.1%
Net Profit YoY
-35.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EPOW
EPOW
ORGO
ORGO
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$150.9M
Q2 25
$22.3M
$101.0M
Q1 25
$86.7M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$22.3M
$130.2M
Net Profit
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
Q2 25
$-6.0M
$-9.4M
Q1 25
$-18.8M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$-4.5M
$-17.0M
Gross Margin
EPOW
EPOW
ORGO
ORGO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
0.1%
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
0.1%
77.6%
Operating Margin
EPOW
EPOW
ORGO
ORGO
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-24.3%
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-24.3%
-10.7%
Net Margin
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
19.4%
Q3 25
14.3%
Q2 25
-27.1%
-9.3%
Q1 25
-21.7%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
-20.0%
-13.1%
EPS (diluted)
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.21
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EPOW
EPOW
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$1.3M
$91.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.3M
Total Assets
$143.0M
$520.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EPOW
EPOW
ORGO
ORGO
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$1.3M
$73.1M
Q1 25
$110.0M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$15.2M
$89.9M
Total Debt
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
$300.1M
Q3 25
$255.1M
Q2 25
$27.3M
$233.2M
Q1 25
$242.9M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$-2.8M
$263.5M
Total Assets
EPOW
EPOW
ORGO
ORGO
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$509.8M
Q2 25
$143.0M
$461.1M
Q1 25
$467.4M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$141.6M
$443.2M
Debt / Equity
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EPOW
EPOW
ORGO
ORGO
Operating Cash FlowLast quarter
$-6.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
$39.4M
Q3 25
$3.1M
Q2 25
$-6.9M
$-32.9M
Q1 25
$-19.9M
Q4 24
$10.9M
Q3 24
$8.7M
Q2 24
$-6.9M
$4.7M
Free Cash Flow
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$-7.9M
$2.9M
FCF Margin
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
-35.6%
2.2%
Capex Intensity
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
4.4%
1.4%
Cash Conversion
EPOW
EPOW
ORGO
ORGO
Q1 26
Q4 25
0.90×
Q3 25
0.14×
Q2 25
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons